Previous studies have shown that PEER measured on CT best distinguishes chRCC from oncocytoma in patients with CD117 + tumours,9, 10 although high accuracy of CT PEER was also seen in a cohort which included tumours with unknown and CD117‐ status.10 Here, KIT is linked to neoplasm.